Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Lyka Labs Ltd

Pharmaceuticals & Biotechnology | Small Cap

Lyka Labs Ltd Health Insights
Health Score : 4.77Health Score : 4.77

Lyka Labs Ltd, operating within the Healthcare Services sector, showcases a mixed financial performance. The company demonstrates strong solvency and profitability, driven by high equity, return on capital employed, and return on assets. However, liquidity remains a significant concern due to negligible current, quick, and cash ratios. Efficiency is also a challenge, with low turnover ratios indicating poor asset utilization. The company shows promise in operating profit and asset growth, but struggles with revenue and net income growth. While interest coverage is reasonable, the absence of equity dividend coverage raises concerns. Overall, Lyka Labs exhibits financial stability and profitability, but needs to address its liquidity and efficiency challenges to ensure long-term sustainability. The weighted average calculation method considers recent years more heavily, so improvements in recent performance could positively impact future assessments.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Lyka Labs Ltd Health Insights
Health Score : 4.77Health Score : 4.77

Lyka Labs Ltd, operating within the Healthcare Services sector, showcases a mixed financial performance. The company demonstrates strong solvency and profitability, driven by high equity, return on capital employed, and return on assets. However, liquidity remains a significant concern due to negligible current, quick, and cash ratios. Efficiency is also a challenge, with low turnover ratios indicating poor asset utilization. The company shows promise in operating profit and asset growth, but struggles with revenue and net income growth. While interest coverage is reasonable, the absence of equity dividend coverage raises concerns. Overall, Lyka Labs exhibits financial stability and profitability, but needs to address its liquidity and efficiency challenges to ensure long-term sustainability. The weighted average calculation method considers recent years more heavily, so improvements in recent performance could positively impact future assessments.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-7.45

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Highly Undervalued

Small Cap Median

27.17

Highly Undervalued

P/E RATIO

-23.98

P/B RATIO

2.60

Neutral

Industry Median

3.17

Neutral
Neutral

Small Cap Median

2.62

Neutral

P/S RATIO

1.88

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

-263.49

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹67.38 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.00

The company's growth performance is mixed. While operating profit and asset growth show promise, revenue and net income growth are lacking. Earnings per share growth is also a concern. This suggests potential for future expansion if revenue and profitability can be improved. The weighted average calculation, which gives more weight to recent data, suggests that improvements in operating profit and asset growth could drive future assessments.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate125.58-52.0619.3524.32-7.25
Operating Profit Growth Rate405-83.17-5.8812.5-122.22
Earnings Per Share (EPS) Growth-437.22-131.64-82.56-398.67-225.45
Asset Growth Rate-2.11-18.283.2912.1-0.57
Net Income Growth Rate-480-134.21-76.92-366.67-225
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The company's financial ratios present a mixed picture. While capital expenditures are well-managed, adjusted earnings per share, book value per share, and dividend per share are low. Cash earnings per share is also a concern. Improvements in profitability and shareholder returns are needed to enhance financial performance. The weighted average calculation method, which emphasizes recent data, suggests that improvements in cash earnings per share and adjusted earnings per share could positively impact future assessments.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)14.14-1.94-0.912.22-2.78
Cash Earnings Per Share (Cash EPS)18.970.323.034.17-0.56
Book Value Per Share4.8314.8420.6128.8925.83
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)7.56.39.212.311.1
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 4.80

The company's profitability is mixed, with strong return on capital employed and return on assets, but weak gross profit, operating, and net margins. This indicates efficient use of capital and assets, but challenges in generating profits from sales. Improving margins is key to enhancing overall profitability. The weighted average calculation method, which emphasizes recent data, suggests that improvements in gross profit and operating margins could positively impact future assessments.

PoorGross Profit MarginPoor
ExcellentReturn on Capital Employed (ROCE)Excellent
PoorReturn on Equity (ROE)Poor
ExcellentReturn on Assets (ROA)Excellent
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin43.33.232.77.97-9.38
Return on Capital Employed (ROCE)615410-6
Return on Equity (ROE)271.43-28.26-4.417.69-10.75
Return on Assets (ROA)54.311.1810.1910.23-2.29
Operating Margin52.0618.2814.4113.04-3.12
Net Margin19.59-13.98-2.75.8-7.81
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency in utilizing its assets is generally weak. While Days Sales in Inventory and Receivable Days are well-managed, fixed asset, inventory, receivables, and capital turnover ratios are low. This could indicate underutilization of assets or inefficiencies in operations. Improvements in asset management could enhance overall performance. The weighted average calculation method, which emphasizes recent data, suggests that the low turnover ratios in recent years have significantly impacted the overall assessment.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.061.371.911.621.47
Inventory Turnover Ratio17.5911.8813.0811.6210.73
Receivables Turnover Ratio14.314.824.713.943.28
Days Sales in Inventory Ratio20.7530.7227.9131.4134.02
Receivable Days25.5175.7377.4992.64111.28
Capital Turnover Ratio2.530.830.991.121.1
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 5.60

The company's coverage ratios are mixed. While the interest coverage ratio is adequate, the absence of equity dividend coverage raises concerns about shareholder returns. Improving both interest and dividend coverage would enhance financial stability and investor confidence. The weighted average calculation method, which emphasizes recent data, suggests that improvements in interest coverage could positively impact future assessments.

GoodInterest Coverage RatioGood
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio3.95-0.080.86.5-3
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency position is strong, characterized by a high equity ratio and low debt ratios. This indicates a robust capital structure and a reduced risk of financial distress. This indicates a high reliance on equity financing. The weighted average calculation, which gives more weight to recent data, suggests that the strong solvency observed in recent years is sustained and impactful.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.820.590.40.160.2
Debt to Equity Ratio4.561.440.670.190.25
Equity Ratio0.180.410.60.840.8
Debt To Asset Ratio0.340.440.290.120.13
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, indicating potential difficulties in meeting its short-term obligations. While maintaining sufficient liquidity is essential for smooth operations, the company's current levels are not sufficient. This necessitates a strategic review of working capital management practices. The weighted average calculation emphasizes recent data, suggesting that the sustained low liquidity over the past few years significantly impacts the overall assessment. Future improvements in current assets and liabilities could improve the company's score.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio0.681.721.741.741.47
Quick Ratio0.61.541.521.51.24
Cash Ratio0.160.30.140.030.02
Operating Cash Flow Ratio0.720.230.050.040.09
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 13 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medico Remedies Ltd6.6137.70Overvalued17.001.5813.00
2SMS Lifesciences India Ltd6.5921.20Undervalued45.0070.6819.00
3Infinium Pharmachem Ltd6.4226.90Neutral22.006.4314.00
4Aarey Drugs & Pharmaceuticals Ltd5.7359.71Neutral7.001.404.00
5Albert David Ltd5.63-272.47Neutral5.00-2.62-1.00
6BPL Ltd5.46-31.11Neutral-4.82-3.00-8.55
7Zim Laboratories Ltd5.4141.96Neutral30.001.116.00
8Quest Laboratories Ltd5.2711.21Neutral18.009.1615.00
9Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
10Lyka Labs Ltd4.77-23.98Neutral-4.00-9.05-10.00
11Krebs Biochemicals & Industries Ltd4.16-5.27Highly Undervalued-4.00-12.49-4.00
12Nectar Lifescience Ltd3.83-2.67Neutral-59.00-2.95-293.00
Management Assessment Summary
OrangeBalanced Management

Lyka Labs demonstrates mixed management effectiveness. Compounded sales growth shows some promise over 5 years, but recent performance has been inconsistent. Profitability has been volatile, with negative figures in several years, though recent improvements are noted. The company's ROCE is low, indicating inefficient capital use. Debt has decreased, which is a positive sign. Promoter holding has increased, suggesting greater alignment with shareholder interests, but FII holdings have declined. Overall, management faces challenges in sustaining profitability and improving capital efficiency.

Category Metric Value Assessment
PROS Promoter Holding 58.16% Increasing promoter holding indicates confidence.
Debt Management Borrowings Decreasing Decreasing debt suggests improved financial prudence.
CONS ROCE 2.54% Low ROCE indicates inefficient capital allocation.
ROE -3.04% Negative ROE reflects poor return on equity.
AverageFinancial Performance & GrowthAverage
PoorCapital Efficiency & ReturnsPoor
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Lyka Labs exhibits moderate risk. While the company has reduced its debt and increased promoter holding, its volatile financial performance and low capital efficiency pose concerns. Fluctuations in sales and profitability, coupled with a negative ROE, indicate potential operational and financial risks.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageSegment performance volatilityAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1069.15Bearish
  3. SMA 2069.93Bearish
  4. SMA 5070.37Bearish
  5. EMA 1068.79Bearish
  6. EMA 2069.46Bearish
  7. EMA 5069.38Bearish
  8. DEMA 1067.86Bearish
  9. DEMA 2068.69Bearish
  10. DEMA 5070.85Bearish
  11. TEMA 1067.45Bullish
  12. TEMA 2067.95Bearish
  13. TEMA 5069.75Bearish
  14. MACD-0.66Bearish
  15. ADX16.75Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI40.70Neutral
  3. CCI-169.69Oversold
  4. ROC 9-5.10Bearish
  5. ROC 14-3.09Bearish
  6. ROC 25-4.26Bearish
  7. Stoch K11.79Oversold
  8. Stoch D12.12Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper72.53Neutral
  3. BB Middle69.93Neutral
  4. BB Lower67.33Neutral
  5. ATR1.57Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI18.45Oversold

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1069.47Bearish
  3. SMA 2070.13Bearish
  4. SMA 5068.00Bearish
  5. EMA 1069.05Bearish
  6. EMA 2069.46Bearish
  7. EMA 5067.89Bearish
  8. DEMA 1068.15Bearish
  9. DEMA 2069.58Bearish
  10. DEMA 5070.95Bearish
  11. TEMA 1067.57Bullish
  12. TEMA 2068.25Bearish
  13. TEMA 5071.44Bearish
  14. MACD-0.09Bearish
  15. ADX22.29Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.61Neutral
  3. CCI-178.74Oversold
  4. ROC 9-4.26Bearish
  5. ROC 14-3.55Bearish
  6. ROC 25-1.89Bearish
  7. Stoch K8.81Oversold
  8. Stoch D10.70Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper72.91Neutral
  3. BB Middle70.13Neutral
  4. BB Lower67.34Neutral
  5. ATR2.13Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI25.44Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1069.81Bearish
  3. SMA 2069.67Bearish
  4. SMA 5063.93Bullish
  5. EMA 1069.22Bearish
  6. EMA 2068.36Bearish
  7. EMA 5065.27Bullish
  8. DEMA 1069.27Bearish
  9. DEMA 2070.67Bearish
  10. DEMA 5069.29Bearish
  11. TEMA 1068.12Bearish
  12. TEMA 2070.42Bearish
  13. TEMA 50N/AN/A
  14. MACD1.52Bearish
  15. ADX37.41Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI50.92Neutral
  3. CCI-72.20Neutral
  4. ROC 9-3.35Bearish
  5. ROC 14-5.76Bearish
  6. ROC 2517.04Bullish
  7. Stoch K9.25Oversold
  8. Stoch D19.24Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper74.55Neutral
  3. BB Middle69.67Neutral
  4. BB Lower64.80Neutral
  5. ATR3.06Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI19.70Oversold

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1068.96Bullish
  3. SMA 2064.14Bullish
  4. SMA 5061.47Bullish
  5. SMA 10062.05Bullish
  6. SMA 20075.26Bearish
  7. EMA 1068.31Bullish
  8. EMA 2065.76Bullish
  9. EMA 5063.03Bullish
  10. EMA 10065.30Bullish
  11. EMA 20075.07Bearish
  12. DEMA 1071.23Bearish
  13. DEMA 2069.43Bullish
  14. DEMA 5063.80Bullish
  15. DEMA 10057.12Bullish
  16. DEMA 20055.71Bullish
  17. TEMA 1071.67Bearish
  18. TEMA 2071.22Bearish
  19. TEMA 5068.30Bullish
  20. TEMA 10061.21Bullish
  21. TEMA 20052.15Bullish
  22. MACD2.92Bullish
  23. ADX25.44Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI62.54Neutral
  3. CCI80.37Neutral
  4. ROC 1420.17Bullish
  5. ROC 2512.56Bullish
  6. Stoch K68.36Neutral
  7. Stoch D69.66Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper74.83Neutral
  3. BB Middle64.14Neutral
  4. BB Lower53.45Neutral
  5. ATR4.19Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI75.81Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2061.07Bullish
  3. SMA 5080.34Bearish
  4. EMA 2064.55Bullish
  5. EMA 5078.32Bearish
  6. DEMA 2057.28Bullish
  7. DEMA 5057.53Bullish
  8. TEMA 2061.03Bullish
  9. TEMA 5051.16Bullish
  10. MACD-4.62Bullish
  11. ADX36.34Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI46.77Neutral
  3. CCI-45.55Neutral
  4. ROC 1415.65Bullish
  5. ROC 25-7.77Bearish
  6. Stoch K72.78Neutral
  7. Stoch D68.18Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper73.46Neutral
  3. BB Middle61.07Neutral
  4. BB Lower48.67Neutral
  5. ATR7.85High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI55.50Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 662.16Bearish
  3. SMA 1281.17Bearish
  4. SMA 24106.13Bearish
  5. EMA 664.18Bearish
  6. EMA 1277.56Bearish
  7. EMA 2493.07Bearish
  8. DEMA 652.47Bullish
  9. DEMA 1256.34Bullish
  10. DEMA 2475.30Bearish
  11. TEMA 653.61Bullish
  12. TEMA 1248.94Bullish
  13. TEMA 2456.94Bullish
  14. MACD-8.23Bearish
  15. ADX23.90Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI43.30Neutral
  3. CCI-192.65Oversold
  4. ROC 25-51.78Bearish
  5. ROC 50-56.94Bearish
  6. Stoch K9.77Oversold
  7. Stoch D30.15Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper167.04Neutral
  3. BB Middle101.03Neutral
  4. BB Lower35.03Neutral
  5. ATR19.87Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI37.55Neutral